The present study was designed to identify the chemical constituents of the methanolic extract of Curcuma longa L. rhizomes and their inhibitory effect on a hepatoma cell line. The methanolic extract was subjected to GC-MS analysis to identify the volatile constituents and the other part of the same extract was subjected to liquid column chromatographic separation to isolate curcumin. The inhibition of cell growth in the hepatoma cell line and the cytopathological changes were studied. GC-MS analysis showed the presence of fifty compounds in the methanolic extract of C. longa. The major compounds were ar-turmerone (20.50 %), β-sesquiphellandrene (5.20 %) and curcumenol (5.11 %). Curcumin was identified using IR, 1H and 13C NMR. The inhibition of cell growth by curcumin (IC50 = 41.69 ± 2.87 μg mL-1) was much more effective than that of methanolic extract (IC50 = 196.12 ± 5.25 μg mL-1). Degenerative and apoptotic changes were more evident in curcumin- treated hepatoma cells than in those treated with the methanol extract. Antitumor potential of the methanolic extract may be attributed to the presence of sesquiterpenes and phenolic constituents including curcumin (0.051 %, 511.39 μg g-1 dried methanol extract) in C. longa rhizomes.

No abstract

The present study was aimed to determine the phytochemical constituents of Salix mucronata Thunb. leaf extracts and their antioxidant activities. Dried leaf powder was extracted with MeOH, MeOH (85%), MeOH(70%) and distilled water. The different extracts were monitored for phytochemical screening. Total phenolic and flavonoid contents were measured by Folin-Ciocalteu and aluminum chloride assays. The antioxidant potential of tested extracts was evaluated using DPPH, ABTS and total antioxidant capacity (TAC) assays. The results showed that, MeOH (85%) extract exhibited high total phenolic and flavonoid contents (TPC=131.39±2.49 mgGAE /g ext. and TFC= 67.69±1.47 mg RE /g ext.). Also, MeOH (85%) extract showed high antioxidant activities (DPPH SC50= 98.76±0.46 (µg/ml), ABTS= 45.83±0.32 mm Trolox ® eq. /100 gm extract and TAC= 199.18±2.19mg equivalent of ascorbic acid /g ext.). On other hand, EtOAc fraction derived from MeOH (85%) extract exhibited the highest antioxidant activity; DPPH SC50= 50.19±0.24 (µg/ml), ABTS= 76.22±1.61(mm Trolox ® eq. /100 gm ext.) and TAC= 249.86±3.74 (mg equivalent of ascorbic acid /g ext.). This study demonstrated that, S. mucronata leaf is a good source of natural antioxidants. Also, there is a high correlation between the total phenolic content and the antioxidant activity.

The antischistosomal activities of L. extracts were evaluated and the characterization of the active secondary metabolites of the defatted methanolic extract was performed using HPLC-ESI-MS. The plant fruit powders were extracted with 85% methanol and fractionated using organic solvents. The antischistosomal effects of the methanolic extracts and its fractions, as well as the assessment of the relationship between the antischistosomal activity of these plant extracts and oxidative stress, was determined. In addition, the defatted methanolic extract was characterized by HPLC-ESI-MS analysis. The number of worms, ova, and the Oogram pattern displayed typical pathology 8 weeks after infection in mice. Treatment of the infected group with the defatted methanolic extracts significantly decreased worm burden, immature ova and mature ova, while increasing the percentage of dead ova The butanol fraction was the most effective fraction reducing worm burden by 77%, ova count in the intestine by 76% and in the liver by 80%, and significantly decreased immature and mature ova (<0.001) compared to the infected group. Additionally, the defatted methanolic extracts improved the reduced glutathione and malondialdehyde levels in hepatic tissues in the treated groups compared to the infected group. The HPLC-ESI-MS analysis of the defatted methanolic extract revealed the presence of several polyphenolic compounds. fruit extracts are rich with phenolic acids and flavonoids and show a significant effect against infections which may be used alternative to PZQ as anti-schistosomal drug against schistosomiasis.

No abstract